5F-AB-FUPPYCA (AZ037): Exploring a New Synthetic Designer Cannabinoid

Buy 5F-AB-FUPPYCA online here at Rcchemsupply your trusted source. Enjoy the benefits of high-quality synthetic cannabinoids conveniently and discreetlyThe world of designer drugs constantly evolves, with new substances emerging from clandestine laboratories. One such compound that has garnered attention is 5F-AB-FUPPYCA (AZ037).

Unlock the World of Synthetic Cannabinoids: Buy 5F-AB-FUPPYCA Online

What is 5F-AB-FUPPYCA (AZ037)?

5F-AB-FUPPYCA (AZ037) belongs to the family of synthetic designer cannabinoids. It is derived from pyrazole, a nitrogen-containing heterocyclic compound. This chemical structure gives it unique properties that interact with the body’s cannabinoid receptors.

 

Synonyms	5F-AB-FUPPYCA AZ-037
IUPAC	N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(5-fluoropentyl)-5-(4-fluorophenyl)-1H-pyrazole-3-carboxamide
Formula	C20H26F2N4O2
Molecular weight	392.44
CAS	2044702-46-5
Appearance	Powder
Purity	≥ 98%

 

Pyrazole-based synthetic designer cannabinoid

Like its predecessors, 5F-AB-FUPPYCA (AZ037) is designed to target the CB1 receptors in the brain. By binding to these receptors, it produces psychoactive effects similar to those of natural cannabinoids found in cannabis plants.

Similarities to 5F-AB-PINACA

5F-AB-FUPPYCA (AZ037) shares similarities with 5F-AB-PINACA, another synthetic cannabinoid. Both compounds act as CB1 receptor agonists, stimulating these receptors and altering neurotransmitter activity in the brain. This results in a range of physical and psychological effects.

Mechanism of Action

CB1 receptor agonist

When consumed, 5F-AB-FUPPYCA (AZ037) interacts with CB1 receptors, which are primarily located in the central nervous system. This interaction leads to the activation of these receptors and subsequent modulation of neurotransmitter release. As a result, various physiological and psychological processes are affected.

Effects on the body

The effects of 5F-AB-FUPPYCA (AZ037) can vary depending on individual tolerance, dosage, and route of administration. Commonly reported effects include euphoria, relaxation, altered perception, increased heart rate, and enhanced sensory experiences. However, it is important to note that these effects can also be accompanied by adverse reactions and risks.

History and Legal Status

Initial mention in 2015

The emergence of 5F-AB-FUPPYCA (AZ037) was first mentioned in 2015, attracting the attention of the scientific community and authorities due to its potential risks and abuse potential. Researchers and regulatory agencies began investigating its properties and effects.

Disappearance as a designer drug

Despite its initial appearance, 5F-AB-FUPPYCA (AZ037) eventually disappeared from the radar of designer drugs. The reasons for its decline in popularity and availability are unclear, but it may be attributed to increased regulation and control measures implemented by authorities.

Legal status in EU countries

As of the present, 5F-AB-FUPPYCA (AZ037) holds legal status in many European Union (EU) countries. However, regulations surrounding synthetic cannabinoids can vary, and it is important to stay updated on the specific legalities in each jurisdiction.

Potential Uses and Risks

Recreational use

Some individuals may use 5F-AB-FUPPYCA (AZ037) for recreational purposes due to its psychoactive effects. However, it is crucial to highlight the potential risks associated with its consumption, including adverse reactions, addiction, and unpredictable effects.

Health risks and safety concerns

The use of synthetic cannabinoids, including 5F-AB-FUPPYCA (AZ037), carries inherent risks. These substances often have limited research, making it difficult to fully understand their long-term effects on the body and mind. Users should be aware of the potential for physical and mental health complications.

Lack of research and regulation

One of the major concerns surrounding 5F-AB-FUPPYCA (AZ037) is the lack of comprehensive scientific research and regulation. Due to its status as a designer drug, studies on its safety, dosage, and potential medical applications are limited. This makes it challenging to provide accurate information and guidance.